GeneHarbor's business model is to generate revenue through technology transfer, which brings in upfront, milestone and royalty payments, product sales and contract research. The Company has successfully completed a number of technology transfers.

GeneHarbor continues to seek development and commercial partners for the broader application of its novel enzymes in food industry, pharmaceutical industry, chemical industry, agriculture and environmental protection.